| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 450.76 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Athletes who abuse recombinant human erythropoietin (rhEPO) consider only the benefit to performance and usually ignore the potential short and long-term liabilities. Elevated haematocrit and dehydratation associated with intense exercise may reveal undetected cardiovascular
risk, but the mechanisms underlying it remain to be fully explained. This study aimed to evaluate the cardiovascular effects of rhEPO in rats under chronic aerobic exercise. A ten week protocol was performed in four male Wistar rat groups: control—sedentary; rhEPO—50 IU kg-1, 3 times/wk; exercised (EX)—swimming for 1 h, 3 times/wk;
EX + rhEPO. One rat of the EX + rhEPO group suffered a sudden death episode during the week 8. rhEPO in trained rats promoted erythrocyte count increase, hypertension,
heart hypertrophy, sympathetic and serotonergic overactivation. The suddenly died rat’s tissues presented brain with
vascular congestion; left ventricular hypertrophy, together with a ‘‘cardiac-liver’’, suggesting the hypothesis of heart
failure as cause of sudden death. In conclusion, rhEPO doping in rats under chronic exercise promotes not only the
expected RBC count increment, suggesting hyperviscosity, but also other serious deleterious cardiovascular and
thromboembolic modifications, including mortality risk, which might be known and assumed by all sports authorities,
including athletes and their physicians.
Descrição
Palavras-chave
rhEPO Doping Chronic aerobic exercise Cardiovascular and mortality risk
Contexto Educativo
Citação
PILOTO, Nuno...[et al.] - Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping. Cardiovascular Toxicology. ISSN 1559-0259. Vol. 9, n.º 4 (2009), p. 201-10
Editora
Humana Press (Springer Imprint)